HK1254636A1 - 作為可溶性鳥苷酸環化酶激活劑的茚滿衍生物及其用途 - Google Patents
作為可溶性鳥苷酸環化酶激活劑的茚滿衍生物及其用途Info
- Publication number
- HK1254636A1 HK1254636A1 HK18113603.2A HK18113603A HK1254636A1 HK 1254636 A1 HK1254636 A1 HK 1254636A1 HK 18113603 A HK18113603 A HK 18113603A HK 1254636 A1 HK1254636 A1 HK 1254636A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- guanylate cyclase
- soluble guanylate
- cyclase activators
- indane derivatives
- indane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562269435P | 2015-12-18 | 2015-12-18 | |
| US201562269408P | 2015-12-18 | 2015-12-18 | |
| PCT/IB2016/057737 WO2017103888A1 (en) | 2015-12-18 | 2016-12-16 | Indane derivatives and the use thereof as soluble guanylate cyclase activators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1254636A1 true HK1254636A1 (zh) | 2019-07-26 |
Family
ID=57708627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18113603.2A HK1254636A1 (zh) | 2015-12-18 | 2018-10-24 | 作為可溶性鳥苷酸環化酶激活劑的茚滿衍生物及其用途 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10316020B2 (zh) |
| EP (1) | EP3390386A1 (zh) |
| JP (1) | JP2018537488A (zh) |
| KR (1) | KR20180095594A (zh) |
| CN (1) | CN108473470A (zh) |
| AU (1) | AU2016370806A1 (zh) |
| CA (1) | CA3008776A1 (zh) |
| HK (1) | HK1254636A1 (zh) |
| IL (1) | IL259934A (zh) |
| RU (1) | RU2018126349A (zh) |
| WO (1) | WO2017103888A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019081456A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | USE OF SGC ACTIVATORS AND STIMULATORS COMPRISING A BETA2 SUBUNIT |
| EP3498298A1 (en) | 2017-12-15 | 2019-06-19 | Bayer AG | The use of sgc stimulators and sgc activators alone or in combination with pde5 inhibitors for the treatment of bone disorders including osteogenesis imperfecta (oi) |
| US20210052528A1 (en) | 2018-04-30 | 2021-02-25 | Bayer Aktiengesellschaft | The use of sgc activators and sgc stimulators for the treatment of cognitive impairment |
| EP3574905A1 (en) | 2018-05-30 | 2019-12-04 | Adverio Pharma GmbH | Method of identifying a subgroup of patients suffering from dcssc which benefits from a treatment with sgc stimulators and sgc activators in a higher degree than a control group |
| CA3126778A1 (en) | 2019-01-17 | 2020-07-23 | Bayer Aktiengesellschaft | Methods to determine whether a subject is suitable of being treated with an agonist of soluble guanylyl cyclase (sgc) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1631260A2 (en) | 2003-02-28 | 2006-03-08 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2009032249A1 (en) | 2007-09-06 | 2009-03-12 | Merck & Co., Inc. | Soluble guanylate cyclase activators |
| AR069517A1 (es) | 2007-12-03 | 2010-01-27 | Smithkline Beecham Corp | Compuesto del acido fenil metiloxifenil piridinil carboxilico substituido, composiciones farmaceuticas que lo comprenden y su uso para la prepara-cion de un medicamento util para el tratamiento de una enfermedad mediada por la actividad de la enzima sgc |
| EP2264017A4 (en) | 2008-04-04 | 2011-07-27 | Takeda Pharmaceutical | Heterocyclic derivative and its use |
| CN102414194A (zh) * | 2009-02-26 | 2012-04-11 | 默沙东公司 | 可溶性鸟苷酸环化酶激活剂 |
| WO2011095553A1 (en) | 2010-02-05 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft | Sgc stimulators or sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| RS54336B1 (en) | 2010-02-05 | 2016-02-29 | Adverio Pharma Gmbh | SGC STIMULATORS OR SGC ACTIVATORS, ONLY FOR YOURSELF AND COMBINED WITH PDE5 INHIBITORS FOR CYST FIBROSIS TREATMENT |
| UA116521C2 (uk) | 2010-05-26 | 2018-04-10 | Адверіо Фарма Гмбх | Застосування sgc-стимуляторів, sgc-активаторів окремо і в комбінації з інгібіторами фде5 для лікування системної склеродермії (ssc) |
| WO2011161099A1 (de) | 2010-06-25 | 2011-12-29 | Bayer Pharma Aktiengesellschaft | Verwendung von stimulatoren und aktivatoren der löslichen guanylatzyklase zur behandlung von sichelzellanämie und konservierung von blutersatzstoffen |
| EP2594270A3 (en) | 2011-11-18 | 2013-07-31 | BIP Patents | The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) |
| PE20151001A1 (es) | 2012-09-07 | 2015-07-15 | Boehringer Ingelheim Int | Alcoxipirazoles como activadores de guanilato ciclasa soluble |
| EP2980085B1 (en) | 2013-03-29 | 2018-03-14 | Teijin Pharma Limited | Pyrazole derivative |
| WO2015011086A1 (en) | 2013-07-25 | 2015-01-29 | Bayer Pharma Aktiengesellschaft | Sgc stimulators or sgc activators and pde5 inhibitors in combination with additional treatment for the therapy of cystic fibrosis |
| US20160214956A1 (en) | 2013-09-05 | 2016-07-28 | Glaxosmithkline Intellectual Property Development Limited | Novel soluble guanylate cyclase activators and their use |
| WO2015095515A1 (en) | 2013-12-20 | 2015-06-25 | Novartis Ag | Sgc activators for the treatment of glaucoma |
| TW201625586A (zh) | 2014-07-02 | 2016-07-16 | 諾華公司 | 環己烯－１－基－吡啶－２－基－１ｈ－吡唑－４－羧酸衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
| TW201625601A (zh) | 2014-07-02 | 2016-07-16 | 諾華公司 | 噻吩－２－基－吡啶－２－基－１ｈ－吡唑－４－羧酸衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
| TW201625584A (zh) * | 2014-07-02 | 2016-07-16 | 諾華公司 | 茚滿及吲哚啉衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
-
2016
- 2016-12-16 CA CA3008776A patent/CA3008776A1/en not_active Abandoned
- 2016-12-16 AU AU2016370806A patent/AU2016370806A1/en not_active Abandoned
- 2016-12-16 JP JP2018531093A patent/JP2018537488A/ja active Pending
- 2016-12-16 WO PCT/IB2016/057737 patent/WO2017103888A1/en active Application Filing
- 2016-12-16 US US16/063,059 patent/US10316020B2/en active Active
- 2016-12-16 CN CN201680079299.1A patent/CN108473470A/zh active Pending
- 2016-12-16 KR KR1020187020080A patent/KR20180095594A/ko unknown
- 2016-12-16 EP EP16820359.4A patent/EP3390386A1/en not_active Withdrawn
- 2016-12-16 RU RU2018126349A patent/RU2018126349A/ru not_active Application Discontinuation
-
2018
- 2018-06-11 IL IL259934A patent/IL259934A/en unknown
- 2018-10-24 HK HK18113603.2A patent/HK1254636A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3390386A1 (en) | 2018-10-24 |
| KR20180095594A (ko) | 2018-08-27 |
| US20190002438A1 (en) | 2019-01-03 |
| WO2017103888A1 (en) | 2017-06-22 |
| CA3008776A1 (en) | 2017-06-22 |
| JP2018537488A (ja) | 2018-12-20 |
| RU2018126349A (ru) | 2020-01-20 |
| US10316020B2 (en) | 2019-06-11 |
| AU2016370806A1 (en) | 2018-07-05 |
| CN108473470A (zh) | 2018-08-31 |
| IL259934A (en) | 2018-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249406A0 (en) | The history of indane and indoline and their use as soluble guanylate cyclase inhibitors | |
| HK1254654A1 (zh) | 4，6-亞嘧啶基衍生物及其用途 | |
| EP3152214A4 (en) | Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activators | |
| IL289276A (en) | Terpanstinil derivatives and preparations containing them and their uses | |
| ZA201701835B (en) | Novel soluble guanylate cyclase activators and their use | |
| IL247836A0 (en) | 1, 3-benzodioxole derivatives, preparations containing them and their uses | |
| IL253656A0 (en) | Mono- and polyazanephthalene modified histories and their use | |
| IL256455B (en) | Phenoxyhalogenphenylamidines and the use thereof as fungicides | |
| EP3079701A4 (en) | Soluble guanylate cyclase activators | |
| EP3079700A4 (en) | Soluble guanylate cyclase activators | |
| IL252757A0 (en) | A work bench and related accessories | |
| EP3310782A4 (en) | Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators | |
| HK1254636A1 (zh) | 作為可溶性鳥苷酸環化酶激活劑的茚滿衍生物及其用途 | |
| EP3303342A4 (en) | Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators | |
| HUE052556T2 (hu) | Expandálható bevonó készítmények és alkalmazásaik | |
| IL246987A0 (en) | Heteroaryl amides, preparations containing it and their uses | |
| EP3008124A4 (en) | STRENGTH COMPOSITIONS AND USE THEREOF | |
| HRP20182050T1 (hr) | Derivati taksana topivi u vodi i njihova uporaba | |
| IL267184A (en) | Phenylamidines and the use thereof as fungicides | |
| HK1254379A1 (zh) | 烯基苯氧基取代的1，1-二苯基乙烯、它們的製備方法和它們的用途 | |
| IL261645A (en) | History of dioxo-hexahydroisoindolyl and their use as cyclophilin inhibitors | |
| HK1250028A1 (zh) | 2-苯基-6-咪唑基-吡啶-4-甲酰胺衍生物及其作為eaat3抑制劑的用途 | |
| IL249122A0 (en) | History of imidazole- or 4,2,1-triazole and their use | |
| IL267258A (en) | Phenoxyphenylamidines and the use thereof as fungicides | |
| IL265821A (en) | Urea derivatives, preparations containing them and their uses |